Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Capital Expenditures (2018 - 2024)

Historic Capital Expenditures for Dna X (SONM) over the last 7 years, with Q4 2024 value amounting to $8000.0.

  • Dna X's Capital Expenditures fell 3333.33% to $8000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $214000.0, marking a year-over-year increase of 132666.67%. This contributed to the annual value of $214000.0 for FY2024, which is 49444.44% up from last year.
  • According to the latest figures from Q4 2024, Dna X's Capital Expenditures is $8000.0, which was down 3333.33% from $137000.0 recorded in Q3 2024.
  • Dna X's 5-year Capital Expenditures high stood at $184000.0 for Q1 2020, and its period low was -$75000.0 during Q4 2020.
  • Its 5-year average for Capital Expenditures is $27785.7, with a median of $9500.0 in 2020.
  • In the last 5 years, Dna X's Capital Expenditures plummeted by 18928.57% in 2020 and then surged by 1360000.0% in 2024.
  • Over the past 5 years, Dna X's Capital Expenditures (Quarter) stood at -$75000.0 in 2020, then soared by 134.67% to $26000.0 in 2021, then plummeted by 92.31% to $2000.0 in 2022, then surged by 500.0% to $12000.0 in 2023, then plummeted by 33.33% to $8000.0 in 2024.
  • Its Capital Expenditures was $8000.0 in Q4 2024, compared to $137000.0 in Q3 2024 and $39000.0 in Q2 2024.